[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627304":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":26,"locations":34,"responsibleParty":168,"collaborators":171,"id":175,"slug":176,"hasResults":177,"nctId":178,"briefTitle":179,"officialTitle":180,"acronym":181,"eligibilityCriteria":182,"healthyVolunteers":177,"sex":183,"minAge":184,"maxAge":185,"enrollmentInfo":186,"targetDuration":11,"studyType":189,"phases":190,"briefSummary":192,"conditions":193,"keywords":11,"overallStatus":141,"whyStopped":11,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":199,"completionDateStruct":201,"leadSponsor":203,"locationsCount":204},{"fullName":5,"class":6},"Tokyo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"MSA-01","EXPERIMENTAL",null,[13],"Drug: MSA-01",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo","PLACEBO_COMPARATOR",[18],"Drug: Placebo",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DRUG","Ubiquinol",[9],{"type":21,"name":15,"description":15,"armGroupLabels":25,"otherNames":11},[15],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":11,"email":31},"Jun Mitsui","CONTACT","+81-3-5800-9762","msa-office@umin.ac.jp",{"name":33,"role":29,"phone":30,"phoneExt":11,"email":31},"Ikue Wada",[35,51,62,73,85,97,108,120,132,139,145,156],{"facility":36,"status":37,"city":38,"state":39,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Nagoya University Hospital","NOT_YET_RECRUITING","Nagoya","Aichi-ken","Japan","JP",{"type":43,"coordinates":44},"Point",[45,46],136.90641,35.18147,{"lat":46,"lon":45},[49],{"name":50,"role":29,"phone":30,"phoneExt":11,"email":31},"Masahisa Katsuno",{"facility":52,"status":37,"city":53,"state":53,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Chiba University Hospital","Chiba",{"type":43,"coordinates":55},[56,57],140.11667,35.6,{"lat":57,"lon":56},[60],{"name":61,"role":29,"phone":30,"phoneExt":11,"email":31},"Atsuhiko Sugiyama",{"facility":63,"status":37,"city":64,"state":64,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Kyushu University Hospital","Fukuoka",{"type":43,"coordinates":66},[67,68],130.41667,33.6,{"lat":68,"lon":67},[71],{"name":72,"role":29,"phone":30,"phoneExt":11,"email":31},"Dai Matsuse",{"facility":74,"status":37,"city":75,"state":76,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Hokkaido University Hospital","Sapporo","Hokkaido",{"type":43,"coordinates":78},[79,80],141.35,43.06667,{"lat":80,"lon":79},[83],{"name":84,"role":29,"phone":30,"phoneExt":11,"email":31},"Ichiro Yabe",{"facility":86,"status":37,"city":87,"state":88,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Kagoshima University Hospital","Kagoshima","Kagoshima-ken",{"type":43,"coordinates":90},[91,92],130.55,31.56667,{"lat":92,"lon":91},[95],{"name":96,"role":29,"phone":30,"phoneExt":11,"email":31},"Yujiro Higuchi",{"facility":98,"status":37,"city":99,"state":99,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Kyoto University Hospital","Kyoto",{"type":43,"coordinates":101},[102,103],135.75385,35.02107,{"lat":103,"lon":102},[106],{"name":107,"role":29,"phone":30,"phoneExt":11,"email":31},"Hodaka Yamakado",{"facility":109,"status":37,"city":110,"state":111,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":112,"geoPoint":116,"contacts":117},"Okayama University Hospital","Okayama","Okayama-ken",{"type":43,"coordinates":113},[114,115],133.93333,34.65,{"lat":115,"lon":114},[118],{"name":119,"role":29,"phone":30,"phoneExt":11,"email":31},"Hiroyuki Ishiura",{"facility":121,"status":37,"city":122,"state":123,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"NHO Higashisaitama National Hospital","Hasuda","Saitama",{"type":43,"coordinates":125},[126,127],139.6491,35.97113,{"lat":127,"lon":126},[130],{"name":131,"role":29,"phone":30,"phoneExt":11,"email":31},"Katsuhisa Ogata",{"facility":133,"status":37,"city":134,"state":135,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":11,"geoPoint":11,"contacts":136},"Institute of Science Tokyo Hospital","Bunkyō-Ku","Tokyo",[137],{"name":138,"role":29,"phone":30,"phoneExt":11,"email":31},"Kinya Ishikawa",{"facility":140,"status":141,"city":134,"state":135,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":11,"geoPoint":11,"contacts":142},"The University of Tokyo Hospital","RECRUITING",[143,144],{"name":28,"role":29,"phone":30,"phoneExt":11,"email":31},{"name":33,"role":29,"phone":30,"phoneExt":11,"email":31},{"facility":146,"status":37,"city":147,"state":135,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"National Center Hospital, National Center of Neurology and Psychiatry","Kodaira",{"type":43,"coordinates":149},[150,151],139.48508,35.72603,{"lat":151,"lon":150},[154],{"name":155,"role":29,"phone":30,"phoneExt":11,"email":31},"Yuji Takahashi",{"facility":157,"status":37,"city":158,"state":159,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Tottori University Hospital","Yonago","Tottori",{"type":43,"coordinates":161},[162,163],133.33333,35.43333,{"lat":163,"lon":162},[166],{"name":167,"role":29,"phone":30,"phoneExt":11,"email":31},"Ritsuko Hanajima",{"type":169,"investigatorFullName":28,"investigatorTitle":170,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Project Associate Professor",[172],{"name":173,"class":174},"Nobelpharma","INDUSTRY","100627304","phase-3-msa-01-in-multiple-system-atrophy-100627304",false,"NCT07446894","MSA-01 in Multiple System Atrophy","A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study of MSA-01 in Patients With Multiple System Atrophy","MSA-01_P3","Inclusion Criteria:\n\nAt the time of informed consent\n\n1. Patients diagnosed as 'clinically established' or 'clinically probable' MSA based on the revised MSA diagnostic criteria of the Movement Disorder Society (MDS).\n2. Patients who are able to walk independently or with the use of assistive devices.\n3. Patients who are able to attend outpatient visits at the participating study site.\n\n   At the start of study drug administration\n4. Patients who are able to discontinue the use of CoQ10 supplements.\n\nExclusion Criteria:\n\n1. Patients with severe neurological disorders, other progressive movement disorders, or cognitive impairment.\n2. Patients with severe liver disease.\n3. Patients with a known history of hypersensitivity to any component of the investigational drug.\n4. Pregnant women, breastfeeding women, or women who may be pregnant.\n5. Patients who have previously participated in a clinical trial of MSA-01.","ALL","30 Years","79 Years",{"count":187,"type":188},140,"ESTIMATED","INTERVENTIONAL",[191],"PHASE3","The purpose of this study is to evaluate whether MSA-01 slows the progression of multiple system atrophy (MSA) and to assess its safety.\n\nThe primary question is:\n\n• Does MSA-01 slow the progression of motor impairment as measured by UMSARS Part 2 score?\n\nParticipants will be randomly assigned to receive MSA-01 or placebo for 12 months. They will attend regular clinic visits for safety and efficacy assessments and record their medication use and any side effects in a diary.",[194],"Multiple System Atrophy (MSA)","2026-03-02",{"date":197,"type":198},"2026-03-04","ACTUAL",{"date":200,"type":198},"2026-02-09",{"date":202,"type":188},"2028-03-31",{"name":5,"class":6},12]